Skip to main content

Advertisement

Log in

Retinal nerve fiber layer thinning: a window into rapid eye movement sleep behavior disorders in Parkinson’s disease

  • Neurology • Original Article
  • Published:
Sleep and Breathing Aims and scope Submit manuscript

Abstract

Purpose

Retinal nerve fiber layer (RNFL) thinning occurs in Parkinson’s disease (PD) and other neurodegenerative diseases. Idiopathic RBD (iRBD) is a well-established prodromal hallmark of synucleinopathies and occurs secondary to many neurodegenerative diseases, including PD. The aim of this study is to determine whether or not retinal structures are altered with the onset of rapid eye movement (REM) sleep behavior disorders (RBD).

Methods

In all, a total of 63 patients with PD, 14 patients with idiopathic RBD, and 26 sex- and age-matched healthy controls were enrolled and underwent optical coherence tomography measurements (HD-OCT (Zeiss) ) for the average and every quadrant of RNFL thickness. The REM Sleep Behavior Disorder Screening Questionnaire (RBDSQ) was used to classify PD patients with clinically probable RBD (PD + pRBD) or without probable RBD (PD − pRBD). Patients with iRBD were identified by polysomnography.

Results

For patients with RBD (idiopathic or secondary to PD), we found a significant decrease in RNFL thickness compared with groups without RBD (PD − pRBD and healthy controls) (all p < 0.05). Average RNFL thickness in patients with iRBD is significantly thinner than in healthy controls (p < 0.05). In PD, the average RNFL thickness was dramatically thinner in the PD + pRBD group than the PD − pRBD group (p < 0.005). Compared with healthy controls, RNFL thickness was slightly thinner in the drug-naive PD group but not the PD group with drug treatment. Multiple linear regression analysis showed that RBDSQ score was negatively associated with average and inferior RNFL variation in PD (all p < 0.005).

Conclusions

The findings show that RNFL was slightly but significantly thinner in idiopathic RBD. In PD, RNFL thickness may vary depending on the presence of RBD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

PD + pRBD:

PD patients with clinical probable RBD

PD − pRBD:

PD patients without probable RBD

RNFL:

Retinal nerve fiber layer

PDND:

newly diagnosed PD patients with drug-naive

PDED:

PD patients exposure to drug treatment

References

  1. Boeve BF, Silber MH, Saper CB, Ferman TJ, Dickson DW, Parisi JE, et al. (2007) Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 130:2770–2788

    Article  CAS  PubMed  Google Scholar 

  2. Boeve BF, Silber MH, Ferman TJ, Lucas JA, Parisi JE (2001) Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 16:622–630

    Article  CAS  PubMed  Google Scholar 

  3. Chiu HF, Wing YK, Lam LC, Li SW, Lum CM, Leung T, et al. (2000) Sleep-related injury in the elderly—an epidemiological study in Hong Kong. Sleep 23:513–517

    Article  CAS  PubMed  Google Scholar 

  4. Schenck CH, Boeve BF, Mahowald MW (2013) Delayed emergence of a parkinsonian disorder dementia in 81 % of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. Sleep Med 14:744–748

    Article  PubMed  Google Scholar 

  5. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839–840

    Article  CAS  PubMed  Google Scholar 

  6. Neikrug AB, Avanzino JA, Liu L, Maglione JE, Natarajan L, Corey-Bloom J, et al. (2014) Parkinson’s disease and REM sleep behavior disorder result in increased non-motor symptoms. Sleep Med 15:959–966

    Article  PubMed  PubMed Central  Google Scholar 

  7. Hu Y, Yu SY, Zuo LJ, Cao CJ, Wang F, Chen ZJ, et al. (2015) Parkinson disease with REM sleep behavior disorder: features, α-synuclein, and inflammation. Neurology 84:888–894

    Article  CAS  PubMed  Google Scholar 

  8. Joutsa J, Gardberg M, Röyttä M, Kaasinen V (2014) Diagnostic accuracy of parkinsonism syndromes by general neurologists. Parkinsonism Relat Disord 20:840–844

    Article  PubMed  Google Scholar 

  9. Theelen T (2014) Photoreceptor layer thinning is not specific for Parkinson’s disease. Mov Disord 29:1331–1332

    Article  PubMed  Google Scholar 

  10. Jiménez B, Ascaso FJ, Cristóbal JA, López DVJ (2014) Development of a prediction formula of Parkinson disease severity by optical coherence tomography. Mov Disord 29:68–74

    Article  PubMed  Google Scholar 

  11. Lee JY, Ahn J, Kim TW, Jeon BS (2014) Optical coherence tomography in Parkinson’s disease: is the retina a biomarker. J Parkinsons Dis 4:197–204

    PubMed  Google Scholar 

  12. Yu JG, Feng YF, Xiang Y, Huang JH, Savini G, Parisi V, et al. (2014) Retinal nerve fiber layer thickness changes in Parkinson disease: a meta-analysis. PLoS One 9:e85718

    Article  PubMed  PubMed Central  Google Scholar 

  13. Kramer SG, Potts AM, Mangnall Y (1971) Dopamine: a retinal neurotransmitter. II. Autoradiographic localization of H3-dopamine in the retina. Investig Ophthalmol 10:617–624

    CAS  Google Scholar 

  14. Harnois C, Di PT (1990) Decreased dopamine in the retinas of patients with Parkinson’s disease. Invest Ophthalmol Vis Sci 31:2473–2475

    CAS  PubMed  Google Scholar 

  15. Beach TG, Carew J, Serrano G, Adler CH, Shill HA, Sue LI, et al. (2014) Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson’s disease subjects. Neurosci Lett 571:34–38

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A (2004) Retinal nerve fiber layer thinning in Parkinson disease. Vis Res 44:2793–2797

    Article  PubMed  Google Scholar 

  17. Moreno-Ramos T, Benito-León J, Villarejo A, Bermejo-Pareja F (2013) Retinal nerve fiber layer thinning in dementia associated with Parkinson’s disease, dementia with Lewy bodies, and Alzheimer’s disease. J Alzheimers Dis 34:659–664

    CAS  PubMed  Google Scholar 

  18. Satue M, Garcia-Martin E, Fuertes I, Otin S, Alarcia R, Herrero R, et al. (2013) Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson’s disease patients. Eye (Lond) 27:507–514

    Article  CAS  Google Scholar 

  19. Nomura T, Inoue Y, Kagimura T, Uemura Y, Nakashima K (2011) Utility of the REM sleep behavior disorder screening questionnaire (RBDSQ) in Parkinson’s disease patients. Sleep Med 12:711–713

    Article  PubMed  Google Scholar 

  20. Poryazova R, Oberholzer M, Baumann CR, Bassetti CL (2013) REM sleep behavior disorder in Parkinson’s disease: a questionnaire-based survey. J Clin Sleep Med 9:55–59A

    PubMed  PubMed Central  Google Scholar 

  21. Montplaisir J, Gagnon JF, Fantini ML, Postuma RB, Dauvilliers Y, Desautels A, et al. (2010) Polysomnographic diagnosis of idiopathic REM sleep behavior disorder. Mov Disord 25:2044–2051

    Article  PubMed  Google Scholar 

  22. American Academy of Sleep Medicine (2007) The AASM manual for the scoring of sleep and associated events—rules, terminology and technical specifications. American Academy of Sleep Medicine, Westchester, IL

    Google Scholar 

  23. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442

    Article  CAS  PubMed  Google Scholar 

  24. Postuma RB, Gagnon JF, Montplaisir J (2013) Rapid eye movement sleep behavior disorder as a biomarker for neurodegeneration: the past 10 years. Sleep Med 14:763–767

    Article  PubMed  Google Scholar 

  25. Postuma RB, Iranzo A, Hogl B, Arnulf I, Ferini-Strambi L, Manni R, et al. (2015) Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study. Ann Neurol 77:830–839

    Article  PubMed  Google Scholar 

  26. Djamgoz MB, Hankins MW, Hirano J, Archer SN (1997) Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vis Res 37:3509–3529

    Article  CAS  PubMed  Google Scholar 

  27. Spund B, Ding Y, Liu T, Selesnick I, Glazman S, Shrier EM, et al. (2013) Remodeling of the fovea in Parkinson disease. J Neural Transm 120:745–753

    Article  CAS  PubMed  Google Scholar 

  28. Sen A, Tugcu B, Coskun C, Ekinci C, Nacaroglu SA (2014) Effects of levodopa on retina in Parkinson disease. Eur J Ophthalmol 24:114–119

    Article  PubMed  Google Scholar 

  29. Tosini G, Menaker M (1996) Circadian rhythms in cultured mammalian retina. Science 272:419–421

    Article  CAS  PubMed  Google Scholar 

  30. Schmoll C, Lascaratos G, Dhillon B, Skene D, Riha RL (2011) The role of retinal regulation of sleep in health and disease. Sleep Med Rev 15:107–113

    Article  PubMed  Google Scholar 

  31. Musiek ES (2015) Circadian clock disruption in neurodegenerative diseases: cause and effect. Front Pharmacol 6:29

    Article  PubMed  PubMed Central  Google Scholar 

  32. Braak H, Del TK, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rüb U (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease (preclinical and clinical stages). J Neurol 249(Suppl 3):III/1–5

    PubMed  Google Scholar 

Download references

Acknowledgments

Chun-feng Liu, Zi-jiao Yang, Cheng-jie Mao conceived and designed the experiments. Zi-jiao Yang, Jing Wei, and Xiao-yan Ji performed the experiments. All authors analyzed the data, discussed the results and co-wrote and commented on the manuscript. All authors have approved the final article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chun-feng Liu.

Ethics declarations

Financial disclosures

All funding sources and potential conflicts of interest from each author that relate to the research were covered in the article.

Funding sources for study

This work was supported by the Jiangsu Provincial Special Program of Medical Science (BL2014042); Suzhou Clinical Key Disease Diagnosis and Treatment Technology Foundation (LCZX201304); and Suzhou Clinical Research Center of Neurological Disease (Szzx201503). This was also partly supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, Zj., Wei, J., Mao, Cj. et al. Retinal nerve fiber layer thinning: a window into rapid eye movement sleep behavior disorders in Parkinson’s disease. Sleep Breath 20, 1285–1292 (2016). https://doi.org/10.1007/s11325-016-1366-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11325-016-1366-4

Keywords

Navigation